Inhibikase Therapeutics Inc (IKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 12,929 | 5,828 | 5,051 | 4,782 | 4,404 |
| Operating Income | -12,929 | -5,828 | -5,051 | -4,782 | -4,404 |
| Other Income | 796 | 49 | 91 | 133 | 226 |
| Pre-tax Income | -12,133 | -5,778 | -4,960 | -4,650 | -4,178 |
| Net Income Continuous | -12,133 | -5,778 | -4,960 | -4,650 | -4,178 |
| Net Income | $-12,133 | $-5,778 | $-4,960 | $-4,650 | $-4,178 |
| EPS Basic Total Ops | 0.88 | -0.65 | -0.66 | -0.73 | -0.49 |
| EPS Basic Continuous Ops | 0.88 | -0.65 | -0.66 | -0.73 | -0.50 |
| EPS Diluted Total Ops | 0.88 | -0.65 | -0.66 | -0.73 | -0.49 |
| EPS Diluted Continuous Ops | 0.88 | -0.65 | -0.66 | -0.73 | -0.50 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.65 | -0.66 | -0.73 | N/A |
| EBITDA(a) | $-12,922 | $-5,821 | $-5,044 | $-4,776 | $-4,397 |